InsidersTradesSigma
리센스메디컬 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 리센스메디컬 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 리센스메디컬 has recorded 9 public disclosures. Market capitalisation: €182.3bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 김건호. All data is openly available.
9
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 30 June 2026
Declarations9 total
9 of 9 declarations
About 리센스메디컬
리센스메디컬 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative medical solutions.